Chris Morehouse

3.3k total citations
42 papers, 2.2k citations indexed

About

Chris Morehouse is a scholar working on Immunology, Oncology and Rheumatology. According to data from OpenAlex, Chris Morehouse has authored 42 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Oncology and 10 papers in Rheumatology. Recurrent topics in Chris Morehouse's work include Cancer Immunotherapy and Biomarkers (12 papers), T-cell and B-cell Immunology (10 papers) and Inflammatory Myopathies and Dermatomyositis (6 papers). Chris Morehouse is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), T-cell and B-cell Immunology (10 papers) and Inflammatory Myopathies and Dermatomyositis (6 papers). Chris Morehouse collaborates with scholars based in United States, China and Spain. Chris Morehouse's co-authors include Brandon W. Higgs, Bahija Jallal, Yihong Yao, Philip Z. Brohawn, Peter A. Kiener, Steven A. Greenberg, Laura K. Richman, Barbara White, Anthony J. Coyle and Wendy I. White and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Gastroenterology.

In The Last Decade

Chris Morehouse

40 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Morehouse United States 24 1.0k 732 632 580 477 42 2.2k
Yutaka Kawakami Japan 22 681 0.7× 376 0.5× 553 0.9× 777 1.3× 915 1.9× 37 2.4k
Erika Darrah United States 23 871 0.9× 1.1k 1.5× 216 0.3× 634 1.1× 335 0.7× 62 2.5k
Jason W. Bauer United States 9 978 1.0× 935 1.3× 366 0.6× 293 0.5× 295 0.6× 10 1.6k
Jörn Drappa United States 21 2.1k 2.1× 1.6k 2.2× 377 0.6× 673 1.2× 469 1.0× 31 3.3k
Pille Harrison United Kingdom 19 662 0.7× 1.0k 1.4× 250 0.4× 229 0.4× 429 0.9× 53 2.0k
François Cornélis France 29 685 0.7× 877 1.2× 145 0.2× 422 0.7× 273 0.6× 62 1.8k
Naoyuki Miyokawa Japan 26 514 0.5× 142 0.2× 719 1.1× 569 1.0× 904 1.9× 124 2.7k
Natalja T. ter Haar Netherlands 26 384 0.4× 220 0.3× 332 0.5× 700 1.2× 677 1.4× 51 2.1k
Deborah S. Cunninghame Graham United Kingdom 18 1.4k 1.3× 1.1k 1.5× 131 0.2× 520 0.9× 296 0.6× 26 2.2k
Raymond E. Felgar United States 22 1.4k 1.3× 813 1.1× 230 0.4× 240 0.4× 486 1.0× 38 2.8k

Countries citing papers authored by Chris Morehouse

Since Specialization
Citations

This map shows the geographic impact of Chris Morehouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Morehouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Morehouse more than expected).

Fields of papers citing papers by Chris Morehouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Morehouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Morehouse. The network helps show where Chris Morehouse may publish in the future.

Co-authorship network of co-authors of Chris Morehouse

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Morehouse. A scholar is included among the top collaborators of Chris Morehouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Morehouse. Chris Morehouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sridhar, Sriram, Luis Paz‐Ares, Hao Liu, et al.. (2019). Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients. Clinical Lung Cancer. 20(6). e601–e608. 37 indexed citations
2.
Higgs, Brandon W., Chris Morehouse, Michael Kuziora, et al.. (2018). IFNγ mRNA signature (IFNγ sig), circulating tumor DNA (ctDNA), and survival in NSCLC or urothelial cancer (UC) treated with durvalumab (D).. Journal of Clinical Oncology. 36(5_suppl). 51–51.
3.
Sands, Bruce E., Jingjing Chen, Brian G. Feagan, et al.. (2017). Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study. Gastroenterology. 153(1). 77–86.e6. 223 indexed citations
4.
Higgs, Brandon W., Yanying Liu, Yinong Sebastian, et al.. (2017). High-throughput RNA sequencing reveals distinct gene signatures in active IgG4-related disease. Scientific Reports. 7(1). 17567–17567. 10 indexed citations
5.
Delaney, Tracy, Chris Morehouse, Philip Z. Brohawn, et al.. (2016). Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease. The Journal of Immunology. 197(1). 42–50. 27 indexed citations
6.
Naing, Aung, Sanjay Goel, Brendan D. Curti, et al.. (2016). A Phase 1 first-in-human study of MEDI0680, an anti-PD-1 monoclonal antibody (mAb) in adult patients (pts) with advanced tumors. Annals of Oncology. 27. vi367–vi367. 1 indexed citations
7.
Xue, Feng, Brandon W. Higgs, Jiaqi Huang, et al.. (2015). HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. Journal of Translational Medicine. 13(1). 379–379. 27 indexed citations
8.
Qu, Bo, Jianchang Cao, Feifei Zhang, et al.. (2015). Type I Interferon Inhibition of MicroRNA‐146a Maturation Through Up‐Regulation of Monocyte Chemotactic Protein–Induced Protein 1 in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 67(12). 3209–3218. 45 indexed citations
10.
Jiang, Liyan, Jiaqi Huang, Chris Morehouse, et al.. (2013). Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients. Cancer Genetics. 206(9-10). 330–339. 14 indexed citations
11.
Peng, Li, Michael D. Oberst, Jia‐Qi Huang, et al.. (2012). The CEA/CD3-Bispecific Antibody MEDI-565 (MT111) Binds a Nonlinear Epitope in the Full-Length but Not a Short Splice Variant of CEA. PLoS ONE. 7(5). e36412–e36412. 27 indexed citations
12.
Zhu, Wei, Katie Streicher, Nan Shen, et al.. (2012). Genomic signatures characterize leukocyte infiltration in myositis muscles. BMC Medical Genomics. 5(1). 53–53. 32 indexed citations
13.
Huang, Jiaqi, Chris Morehouse, Katie Streicher, et al.. (2011). Altered Expression of Insulin Receptor Isoforms in Breast Cancer. PLoS ONE. 6(10). e26177–e26177. 52 indexed citations
14.
Karnell, Jodi L., Fredrick G. Karnell, Geoffrey L. Stephens, et al.. (2011). Mycophenolic Acid Differentially Impacts B Cell Function Depending on the Stage of Differentiation. The Journal of Immunology. 187(7). 3603–3612. 64 indexed citations
15.
Greenberg, Steven A., Brandon W. Higgs, Chris Morehouse, et al.. (2011). Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. Genes and Immunity. 13(3). 207–213. 114 indexed citations
16.
Salajegheh, Mohammad, Jack L. Pinkus, Anthony A. Amato, et al.. (2010). Permissive environment for B‐cell maturation in myositis muscle in the absence of B‐cell follicles. Muscle & Nerve. 42(4). 576–583. 54 indexed citations
17.
Zhu, Wei, Brandon W. Higgs, Chris Morehouse, et al.. (2010). A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children. Vaccine. 28(16). 2865–2876. 48 indexed citations
18.
Salajegheh, Mohammad, Sek Won Kong, Jack L. Pinkus, et al.. (2009). Interferon‐stimulated gene 15 ( ISG15 ) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Annals of Neurology. 67(1). 53–63. 148 indexed citations
19.
Yao, Yihong, Brandon W. Higgs, Chris Morehouse, et al.. (2008). Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus. PubMed. 1(1). 100 indexed citations
20.
Yao, Yihong, Laura K. Richman, Chris Morehouse, et al.. (2008). Type I Interferon: Potential Therapeutic Target for Psoriasis?. PLoS ONE. 3(7). e2737–e2737. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026